Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer | Patent Number 10702508

US 10702508 B2
Application Number15967452
Publication NumberUS 20190111036 A1
Pendency2 years, 2 months, 9 days
Filled DateApr 30, 2018
Priority DateOct 16, 2017
Publication DateApr 18, 2019
Expiration DateOct 15, 2037
Inventor/ApplicantsArturo Molina
ExaminesWEDDINGTON, KEVIN E
Art Unit1629
Technology Center1600
Assignments
Aragon Pharmaceuticals Inc.
Current
Aragon Pharmaceuticals Inc.Johnson & Johnson
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.